Cargando…
Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial
INTRODUCTION: The novel coronavirus pandemic (COVID–19) represents a major public health problem and it is key to find a treatment that reduces mortality. Our objective was to estimate whether treatment with 400 mg/day of Hydroxychloroquine for 10 days reduces in-hospital mortality in subjects with...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478184/ https://www.ncbi.nlm.nih.gov/pubmed/34582477 http://dx.doi.org/10.1371/journal.pone.0257238 |